Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001104659-16-162330

Chief Scientific Officer bought 5,000 shares at $2.08 ($10,375)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Erlander Mark Chief Scientific Officer 2016-12-14 Purchase +5,000 $2.08 $10,375 5,000 D: show line 1 in the form
Open-market purchases · 5,000 sh · avg $2.08 · $10,375
Loading xslF345X03/a4.xml…